Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Runhong Zhou

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Natural Product Research|September 16, 2024
A new tetrahydroxybenzophenone from a marine-associated fungus of <i>penicillium</i> sp. and its potential antibacterial activityRuifeng Huang, Shuaiqi Ma, Jiale Wu, et al.
Biochemical Pharmacology|March 14, 2023
Phenolic compound SG-1 from Balanophora harlandii and its derivatives exert anti-influenza A virus activity via activation of the Nrf2/HO-1 pathwayRunhong Zhou, Jianan Hu, Jingnan Qiu, et al.
Fitoterapia|December 24, 2021
New anti-influenza A viral norsesquiterpenoids isolated from feces-residing Streptomyces spShengsheng Lu, Xi Xie, Jianan Hu, et al.
Journal of Medicinal Chemistry|December 15, 2023
A Hybrid Antimicrobial Peptide Targeting <i>Staphylococcus aureus</i> with a Dual Function of Inhibiting Quorum Sensing Signaling and an Antibacterial EffectHaixing Lin, Li Song, Shaofen Zhou, et al.
Cellular & Molecular Immunology|October 12, 2022
Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2Qiaoli Peng, Runhong Zhou, Na Liu, et al.
Frontiers in Immunology|October 7, 2016
Comparative Analysis of Immune Activation Markers of CD8<sup>+</sup> T Cells in Lymph Nodes of Different Origins in SIV-Infected Chinese Rhesus MacaquesJinbiao Liu, Qianhao Xiao, Runhong Zhou, et al.
Cell Host & Microbe|April 18, 2022
35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitopeXiaofei Wang, Xiangyu Chen, Jiaxing Tan, et al.
Ebiomedicine|March 6, 2022
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong KongQiaoli Peng, Runhong Zhou, Yuewen Wang, et al.
Journal of Virology|July 9, 2026
Glucagon-like peptide-1 receptor agonist prevents pulmonary fibrosis following acute COVID-19 infection associated with type 2 diabetesRunhong Zhou, Ming Yue, Qing Shen, et al.
Ebiomedicine|April 17, 2025
An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19Yik Chun Wong, Derek Hoi Hang Ho, Runhong Zhou, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Natural Product Research|September 16, 2024
A new tetrahydroxybenzophenone from a marine-associated fungus of <i>penicillium</i> sp. and its potential antibacterial activityRuifeng Huang, Shuaiqi Ma, Jiale Wu, et al.
Biochemical Pharmacology|March 14, 2023
Phenolic compound SG-1 from Balanophora harlandii and its derivatives exert anti-influenza A virus activity via activation of the Nrf2/HO-1 pathwayRunhong Zhou, Jianan Hu, Jingnan Qiu, et al.
Fitoterapia|December 24, 2021
New anti-influenza A viral norsesquiterpenoids isolated from feces-residing Streptomyces spShengsheng Lu, Xi Xie, Jianan Hu, et al.
Journal of Medicinal Chemistry|December 15, 2023
A Hybrid Antimicrobial Peptide Targeting <i>Staphylococcus aureus</i> with a Dual Function of Inhibiting Quorum Sensing Signaling and an Antibacterial EffectHaixing Lin, Li Song, Shaofen Zhou, et al.
Cellular & Molecular Immunology|October 12, 2022
Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2Qiaoli Peng, Runhong Zhou, Na Liu, et al.
Frontiers in Immunology|October 7, 2016
Comparative Analysis of Immune Activation Markers of CD8<sup>+</sup> T Cells in Lymph Nodes of Different Origins in SIV-Infected Chinese Rhesus MacaquesJinbiao Liu, Qianhao Xiao, Runhong Zhou, et al.
Cell Host & Microbe|April 18, 2022
35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitopeXiaofei Wang, Xiangyu Chen, Jiaxing Tan, et al.
Ebiomedicine|March 6, 2022
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong KongQiaoli Peng, Runhong Zhou, Yuewen Wang, et al.
Journal of Virology|July 9, 2026
Glucagon-like peptide-1 receptor agonist prevents pulmonary fibrosis following acute COVID-19 infection associated with type 2 diabetesRunhong Zhou, Ming Yue, Qing Shen, et al.
Ebiomedicine|April 17, 2025
An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19Yik Chun Wong, Derek Hoi Hang Ho, Runhong Zhou, et al.
Pageof 5